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A B S T R A C T
Synaptic function and neurotransmitter release are regulated by specific proteins. Cortical neuronal differ-
entiation of human induced pluripotent stem cells (hiPSC) provides an experimental model to obtain more
information about synaptic development and physiology in vitro. In this study, expression and secretion of the
synaptic proteins, neurogranin (NRGN), growth-associated protein-43 (GAP-43), synaptosomal-associated pro-
tein-25 (SNAP-25) and synaptotagmin-1 (SYT-1) were analyzed during cortical neuronal differentiation. Protein
levels were measured in cells, modeling fetal cortical development and in cell-conditioned media which was used
as a model of cerebrospinal fluid (CSF), respectively. Human iPSC-derived cortical neurons were maintained
over a period of at least 150 days, which encompasses the different stages of neuronal development. The dif-
ferentiation was divided into the following stages: hiPSC, neuro-progenitors, immature and mature cortical
neurons. We show that NRGN was first expressed and secreted by neuro-progenitors while the maximum was
reached in mature cortical neurons. GAP-43 was expressed and secreted first by neuro-progenitors and its ex-
pression increased markedly in immature cortical neurons. SYT-1 was expressed and secreted already by hiPSC
but its expression and secretion peaked in mature neurons. SNAP-25 was first detected in neuro-progenitors and
the expression and secretion increased gradually during neuronal stages reaching a maximum in mature neu-
rons. The sensitive analytical techniques used to monitor the secretion of these synaptic proteins during cortical
development make these data unique, since the secretion of these synaptic proteins has not been investigated
before in such experimental models. The secretory profile of synaptic proteins, together with low release of
intracellular content, implies that mature neurons actively secrete these synaptic proteins that previously have
been associated with neurodegenerative disorders, including Alzheimer's disease. These data support further
studies of human neuronal and synaptic development in vitro, and would potentially shed light on the me-
chanisms underlying altered concentrations of the proteins in bio-fluids in neurodegenerative diseases.
1. Introduction
Neurons are connected by synapses that form the functional units in
neuronal communication. Because of their ability to undergo various
chemical and electrical changes during learning processes, synapses are
the most essential components of the connectome in the brain; a sy-
napse serves as a transmission line between the pre- and post-synaptic
terminal of two connected units in the connectome (Abbas et al., 2018).
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Synapses contain specific scaffolding and signaling molecules and re-
ceptors that are essential for neurotransmitter release and signal
transduction (Eagle et al., 1959). Synapse formation in the human
neocortex begins in the third trimester of gestation and continues
during the first two postnatal years. Synaptogenesis occurs during the
same period, when dendritic and axonal growth and myelination are
initiated (Huttenlocher and Dabholkar, 1997). Pre- and post-synaptic
proteins interact to promote synaptic development and tuning of cor-
tical circuits (Pinto et al., 2013). In CNS disorders, particularly in
neurodegenerative diseases such as Alzheimer's disease (AD), synapses
become dysfunctional and undergo degeneration (Blennow et al., 1996;
Davies et al., 1987; DeKosky and Scheff, 1990). Several synaptic pro-
teins including neurogranin (NRGN), synaptosomal-associated protein-
25 (SNAP-25), growth-associated protein-43 (GAP-43), synaptotagmin-
1 (SYT-1) and others can be detected in cerebrospinal fluid (CSF), and
have been identified as being released at increased concentrations
during neurodegeneration (Blennow, 2004; Brinkmalm et al., 2014;
Thorsell et al., 2010; Öhrfelt et al., 2016), while their protein con-
centrations decreased in the brain (Davidsson and Blennow, 1998).
These synaptic proteins are detected in CSF from healthy individuals
(albeit at a lower concentration than in AD CSF), showing that they are
secreted into the brain interstitial fluid in vivo also in the absence of
synaptic injury (Brinkmalm et al., 2014; Thorsell et al., 2010; Öhrfelt
et al., 2016).
NRGN (also known as RC3, canarigranin, B-50-immunoreactive C-
kinase substrate (BICKS) or p17) is a 78 amino acid postsynaptic protein
that is expressed abundantly in the cerebral cortex, hippocampus,
amygdala and caudate-putamen in human brain (Represa et al., 1990).
It is a neuron-specific protein and its expression is absent in glial cells in
the central nervous system (Diez-Guerra, 2010; Gnatenko et al., 2003).
NRGN is a calmodulin (CaM)-binding protein and has a role in synaptic
plasticity by regulating CaM-mediated signaling and facilitating long
term potentiation (LTP) (Zhong et al., 2015). It is suggested to be in-
volved in neuronal growth and differentiation via protein kinase C
(PKC) and extracellular signal-regulated kinases 1 and 2 (ERK1/2)
signaling pathways (Han et al., 2007).
GAP-43, also known as neuromodulin, B-50, P-57, F1 or pp46, is a
presynaptic protein that plays an important role during neuronal de-
velopment when it is highly expressed in neuronal growth cones
(Benowitz and Routtenberg, 1997). It is suggested that primary sensory
neurons that lack GAP-43 in their growth cones are deficient in adhe-
sion, spreading, branching and devoid of f-actin (Aigner and Caroni,
1995; Benowitz and Routtenberg, 1997). Furthermore, GAP-43 is sug-
gested to be involved in LTP and long term depression (LTD) and its
expression is related to axonal elongation and synaptic sprouting
(Denny, 2006; Routtenberg et al., 2000).
Synaptotagmins (SYTs) are a family of synaptic vesicle proteins. The
mammalian synaptotagmin family has 15 members. SYT-1 is a pre-sy-
naptic calcium-binding synaptic vesicle protein known to be expressed
in cerebral cortex, hippocampus and cerebellum (Chen et al., 2013;
Sudhof and Rizo, 2011). It is suggested that SYT-1 has a role in exo-
cytosis and endocytosis, synapse function, behavioral cognition, neu-
ronal polarity, axon differentiation, neuro-development and activity-
induced remodeling of synaptic structures (Baker et al., 2015; Inoue
et al., 2013, 2015; Sudhof and Rizo, 2011).
SNAP-25 is an essential component of the soluble N-ethylmalei-
mide-sensitive factor attachment protein receptor (SNARE) complex;
the SNARE complex is needed for several biological processes
throughout neuronal development. SNAP-25 helps in synaptic com-
munication by mediating fusion of synaptic vesicles to the plasma
membrane during exocytosis and regulating calcium dynamics and
neuronal plasticity (Cupertino et al., 2016; Zylbersztejn and Galli,
2011). Both SNAP-25 and SYT-1 interactions are involved in vesicle
priming and in neurotransmission (Schupp et al., 2016).
Previously, NRGN, SNAP-25, SYT-1 and GAP-43 expression has
been studied in monkeys and rodents during development (Alvarez-
Bolado et al., 1996; Capone et al., 1991; Cooper and Gillespie, 2011;
Frassoni et al., 2005; Fukuda, 2006; Higo et al., 2006; Mahalik et al.,
1992; Murata et al., 2005; Sidor-Kaczmarek et al., 2004) and in human
post-mortem brains (Bogdanovic et al., 2000; Furuya et al., 2012). The
proteins are also secreted from neurons into the brain interstitial fluid
that communicates with the CSF (Blennow et al., 2010). In neurode-
generative diseases such as AD, brain levels of synaptic proteins are
commonly reduced, whilst the CSF concentrations are higher (Blennow,
2004; Brinkmalm et al., 2014; Thorsell et al., 2010; Öhrfelt et al.,
2016). However, human and rodent brain development varies greatly.
Further, it is not possible to study the expression and secretion of sy-
naptic proteins during human fetal brain development.
The possibility to reprogram human somatic cells to pluripotent
stem cells has opened ways to develop cell models to study human brain
development and physiology (Takahashi et al., 2007). Human induced
pluripotent stem cells (hiPSC) were differentiated to cortical neurons
using a protocol that follows the same cortical development steps and
time frames as observed in human fetal cortex (Shi et al., 2012). During
this process, we studied the expression and secretion of NRGN, GAP-43,
SYT-1 and SNAP-25. These proteins were sequentially expressed and
secreted over a period of at least 150 days, which encompasses the
different stages of neuronal development.
2. Material and methods
2.1. Cell culture
Two different hiPSC lines were used in this study, femoral condyle
chondrocyte-derived hiPSC (A2B) (Boreström et al., 2014) and fibro-
blast-derived hiPSC (Con1) (Sposito et al., 2015). A2B hiPSC were
cultured on coat-1 in DEF-CS medium (Cellartis, Takara-Bio Europe)
while Con1 hiPSC were cultured on Geltrex in complete Essential-8
medium (both from Thermo Fisher Scientific) according to the manu-
facturer's instructions. All cell cultures were kept in a humidified at-
mosphere at 5% CO2 and 37 °C.
2.2. Differentiation to cortical neurons
A previously described protocol (Shi et al., 2012), with slight
modifications (Bergström et al., 2016), was followed to differentiate
hiPSC to cortical neurons. In brief, when hiPSC attained 95–100%
confluency, neural induction was initiated by replacing either DEF-CS
or complete Essential-8 medium with neural maintenance medium
(NMM; a 1:1 mixture of DMEM/F12 and neurobasal medium supple-
mented with: 1x N2, 1x B27, 50 μM 2-mercaptoethanol, 0.5x non-es-
sential amino acids (all from Thermo Fisher Scientific), 2500 U/mL
Penicillin/Streptomycin (GE Healthcare), 10 μg/mL insulin and 0.5 mM
sodium pyruvate (all from Sigma Aldrich)) further supplemented with
500 ng/mL mouse Noggin-CF chimera (R&D Systems) and 10 μM
SB431542 (Tocris). Cells were maintained in this medium for 10–12
days to attain neuro-epithelial cell morphology followed by passaging
with 10mg/mL dispase (Thermo Fisher Scientific) and plating on la-
minin-coated plates (surface coverage of 1 μg/cm2 laminin coating so-
lution; Sigma Aldrich) in NMM supplemented with 20 ng/mL FGF-2
(Peprotech) for 4–5 days. Thereafter, cells were further passaged twice
using dispase between days 12–22 and with StemPro Accutase®
(Thermo Fisher Scientific) between days 25–35 to obtain single cells.
On the 35th day of differentiation, immature cortical neurons were
seeded on plates pre-coated overnight with poly-L-ornithine (0.01%
coating solution; Sigma Aldrich), followed by laminin (as above) for at
least 4 h. The cells were seeded at 50,000 cells/cm2 and thereafter
maintained for three to seven months in NMM with change of media
every second day to achieve mature cortical neurons (Shi et al., 2012).
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2.3. Immunocytochemistry
For immunocytochemistry, we followed Shi et al. protocol (Shi
et al., 2012). In brief, cells were cultured on 8 well μ-slides and fixed in
4% paraformaldehyde in PBS for 15min at room temperature (RT) or
ice cold methanol at 4 °C. Thereafter, cells were permeabilized for
15min at RT using 0.3% Triton-X100 (Sigma Aldrich) in PBS, followed
by blocking in block buffer (5% donkey serum (Sigma Aldrich) in 0.3%
Triton-X100 diluted in PBS). Primary antibodies, OCT-4 (1:400; Cell
Signaling, D73G4), NANOG (1:800, Cell Signaling, C30A3), TUJ-1
(1:2000; Abcam ab14545), SV-2 (1:500; DSHB), PSD-95 (1:100; Neu-
roMab, P78352), KI-67 (1:600; BD Pharmingen™, 550609), PAX-6
(1:600; BioLegend, 901301), nestin (1:50; R&D Systems, MAB1259),
CTIP-2 (1:300; Abcam, ab18465), TBR-1 (1:300; Abcam, ab31940),
BRN-2 (1:400; Santa Cruz, sc-6029), CUX-1 (1:300; Santa Cruz, sc-
13024), GAP-43 (1:1000; Abcam, ab75810), tau (1:1000; Biorbyt,
orb175815), NRGN (1:100; Upstate Biotechnologies, 07–425), SNAP-25
(1:400; Sigma Aldrich, S9684-100UL) and SYT-1 antibody (1:200; Sy-
naptic systems, 105,011) were diluted in block buffer and incubated at
4 °C overnight. The next day cells were washed with PBS and incubated
with secondary alexa488- and alexa568-conjugates (Life technologies)
at RT for 1 h followed by incubation with DAPI (Thermo Fisher Scien-
tific, D3571) for 5min at RT. The cells were mounted with mounting
media (Ibidi) and imaged using either Zeiss LSM700 inverted confocal
microscope with 40–63× objectives using ZEN2000 software (Zeiss) or
Nikon confocal microscope A1 with 40–60×objectives using the Nis
Elements software (Nikon). Confocal images were analyzed using Im-
ageJ (NIH).
2.4. Total RNA extraction and cDNA synthesis
For total RNA extraction, the cell layer was washed with pre-
warmed Dulbecco's Phosphate-Buffered Saline without calcium and
magnesium (DPBS (−/−); Thermo Fisher Scientific), followed by ad-
dition of 600 μL of RNeasy Lysis Buffer (Qiagen) supplemented with
4mM dithiothreitol (Sigma Aldrich) to lyse the cells. The cell lysates
were stored at −80 °C until further analysis. Total RNA was extracted
and purified using a Qiacube robotic work station (Qiagen), following
the RNeasy Mini protocol as per the manufacturer's instructions. Total
RNA concentrations were determined on a NanoDrop 2000/2000c
spectrophotometer (Thermo Fisher Scientific) followed by dilution of
total RNA in RNase-free water to a final concentration of 100 ng/μL
cDNA synthesis was performed using the High Capacity cDNA kit with
RNase inhibitor (Applied Biosystems). Briefly, total RNA (500 ng) was
converted to cDNA in a reaction volume of 20 μL using a single-cycle
reaction on a 2720 Thermal Cycler (Applied Biosystems): 25 °C for
10min, 37 °C for 120min and 85 °C for 5min. The cDNA was finally
adjusted to a concentration of 0.5 ng/uL before being used in the
quantitative PCR reactions.
2.5. Quantitative PCR
Quantitative PCR was performed using TaqMan® Gene Expression
Assays with FAM reporter dye in TaqMan® Universal PCR Master Mix
with UNG according to the manufacturer's instructions. Quantitative
PCR reactions were carried out on Micro-Amp™ 96-well optical mi-
crotitre plates on the 7900HT Fast QPCR System (Applied Biosystems)
using standard settings. TaqMan® Gene Expression Assays were used for
NRGN (Hs00382922_m1), GAP-43 (Hs00967138_m1), SNAP-25
(Hs00938962_m1) and SYT-1 (Hs00194572_m1) (all from Applied
Biosystems). Each reaction mixture consisted of 2.5 ng of cDNA and was
run in duplicates. Quantitative PCR results were analyzed using the SDS
2.3 software (Applied Biosystems). The relative quantities were calcu-
lated following the ΔΔCT method (Livak and Schmittgen, 2001).
Average CT:s of RPL-27 (Hs03044961_g1), RPL-30 (Hs00265497_m1)
and HPRT-1 (Hs02800695_m1) were used as endogenous controls. All
samples were normalized to the endogenous controls; the sample with
the highest ratio was determined in each run and all the other samples
were then compared to that sample (which was set to 1).
2.6. Western blot
Cells were collected for detecting intracellular protein expression
during differentiation and frozen at −80 °C until further analysis. Cells
were lysed in Radio-Immunoprecipitation Assay buffer (RIPA buffer;
20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
0.5% deoxycholate, 0.1% SDS) supplemented with Mini-Complete
protease inhibitor cocktail (Roche, Sigma-Aldrich, 04693159001) fol-
lowed by sonication for 10 min and incubation on ice for 20 min. The
lysates were centrifuged at 4000 g for 5 min at +4 °C and the super-
natants were transferred to new tubes. Protein concentrations were
determined using the Pierce BCA protein assay kit (Thermo Fisher
Scientific). Samples were stored at −80 °C until further analysis.
Nu-PAGE loading buffer containing SDS reducing agent was added
to aliquots of the protein samples, and after heating to +95 °C for
5 min, samples were either loaded onto 4–12% Bis-tris gels (for NRGN,
GAP-43 and SNAP-25) or 3–8% Tris-acetate gels (SYT-1) using XT MES
running buffer (all from BioRad Laboratories) or NUPAGE Tris-acetate
SDS running buffer (Thermo Fisher Scientific), respectively. The sepa-
rated proteins were blotted onto a 0.2 μm nitrocellulose membrane (GE
Healthcare) using semi-dry technique, followed by blocking in 3%
(NRGN) or 5% (GAP-43, SYT-1, SNAP-25) non-fat milk (BioRad
Laboratories) and overnight incubation at +4 °C with either anti-NRGN
antibody Ab270 (1:5000; gift from Dr. Kuo-Ping Huang (Late)), anti-
GAP-43 antibody [EP890Y] (1:100,000; Abcam, ab75810), anti-SYT-1
antibody (1:2000; Synaptic systems, 105,011), and anti-SNAP-25 anti-
body (1:20,000; Sigma Aldrich, S9684-100UL). After washing, mem-
branes were incubated with horseradish peroxidase (HRP)-conjugated
anti-mouse or anti-rabbit secondary antibody (1:40,000 Cell Signaling
Technologies) for 1 h at RT. For protein detection, SuperSignal West
Dura Extended Duration Substrate (Thermo Fisher Scientific) was used
and bands were visualized using ChemiDoc XRS+ (BioRad
Laboratories). Membranes were thereafter stripped using Restore
stripping buffer (ThermoFisher Scientific) and re-probed with an HRP-
conjugated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) anti-
body (Novus Biologicals). All band intensities were analyzed using
ImageJ (NIH); expression of NRGN, GAP-43, SYT-1 and SNAP-25 in-
tensity was correlated to GAPDH. All samples were thereafter related to
the sample with highest synaptic protein expression to GAPDH ratio
(which was set to 1) in each differentiation batch.
2.7. Cell culture media sample collection
Cell-conditioned media were collected after 48 h of incubation with
cells and centrifuged at 360 g for 5min (to remove cell debris) before
the supernatants were transferred to new tubes and stored at −80 °C
until further analysis.
2.8. Neurogranin ELISA
NRGN concentration in cell-conditioned media was measured using
an in house sandwich ELISA. The Ng36 monoclonal antibody (in house)
was used as capturing antibody and was coated on Nunc Maxisorp 96-
well microtiter plates at a final concentration of 0.5 μg/mL (100 μL/
well) in 50mM sodium bicarbonate buffer, pH 9.6, overnight at 4 °C. All
washes were performed in PBS-T (0.05% Tween20 in PBS (0.01M
phosphate buffer, 0.14M NaCl, pH 7.4). The remaining protein-binding
sites were blocked with 1% bovine serum albumin (BSA) in PBS for 1 h
at 20 °C (250 μL/well). Thereafter, plates were washed with PBS-T
followed by the addition of calibrators (full length NRGN with con-
centrations from 7.8 to 1000 pg/mL, blanks, quality control (QC)
samples and media samples (100 μL/well)). After washing, biotinylated
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Ng2 (in house) detection antibody (0.5 μg/mL in PBS-T) was added and
incubated for 1 h at RT. After washing, enhanced streptavidin HRP
(Enhanced Streptavidin-HRP, 4740 N, Kem En Tech) was diluted
1:20000 in 1% BSA-PBS-T and incubated (100 μL/well) for 30min at RT
followed by three washes. After a final wash, 100 μL of 3,3′,5,5′-tetra-
methylbenzidine (TMB One Solution, 4380A, Kem En Tech) was added
to produce the color reaction. After 20min incubation in the dark, the
reaction was stopped by addition of 100 μL of 0.2M H2SO4 and the
absorbance was measured at 450 nm (reference wavelength 650 nm)
using an ELISA plate reader (Vmax, Molecular Devices, USA). A fitted 4-
parameter logistic model was used to generate the calibration curve and
the blank was included as zero concentration of NRGN.
2.9. GAP-43 ELISA
GAP-43 concentration was measured using an in house sandwich
ELISA (Sandelius et al., 2018). Nunc-Immuno Polysorp microwell
modules (Thermo Fisher Scientific) were coated with mouse anti-GAP-
43 antibody (0.77 μg/mL NM4 ((Fujirebio, Ghent, Belgium)) in 50mM
sodium bicarbonate buffer pH 9.6, overnight at 4 °C. After washing,
wells were blocked with PBS-T, 1x Casein (diluted from 10x casein
blocking buffer, B6429, Sigma-Aldrich) for 1 h at RT. Thereafter, in
house recombinant full-length GAP-43 calibrators (78 pg/mL –
50000 pg/mL), blanks, two folds pre-diluted control samples and media
samples in assay diluent (PBS-T, 1% BSA) were co-incubated with a
rabbit detector antibody (0.14 μg/mL ABB-135 (Nordic Biosite, Täby,
Sweden)) overnight at 4 °C. After additional washes, plates were in-
cubated with anti-rabbit HRP (1:30000, Promega) for 1.5 h. After
subsequent washes, wells were incubated for 20min with TMB (TMB,
KemEnTech Diagnostics) in the dark. The color reaction was stopped by
addition of 100 μL 0.2M H2SO4 and the absorbance was read in a
SunriseTM micropl ate absorbance reader (Tecan) at 450 nm (650 nm
as reference value).
2.10. In-house SNAP-25 and SYT-1 IP-MS assay
The combined SNAP-25 and SYT-1 assay was conducted at the
Clinical Neurochemistry Laboratory at the Sahlgrenska University
Hospital (Mölndal, Sweden) and consists of immuno-enrichment com-
bined with liquid chromatography/tandem mass spectrometry (LC-MS/
MS (Brinkmalm et al., 2014; Fernstrom et al., 2018; Öhrfelt et al.,
2016). Briefly, mouse monoclonal antibody 41.1 recognizing SNAP-25
and mouse monoclonal antibody SMI-81R recognizing SYT-1 were used
to co-immunoprecipitate both proteins with a KingFisher™ Flex System
(Thermo Fisher Scientific), which uses magnetic rods to move particles
through the various binding, mixing, washing and elution phases in a
96-well plate format. Immunoprecipitated SNAP-25/SYT-1 together
with isotopically labeled protein and peptide standards were subse-
quently digested with trypsin/Lys-C and analyzed on a quad-
rupole–orbitrap mass spectrometer Q Exactive (Thermo Fisher Scien-
tific) coupled to an Ultimate 3000 chromatography system (Thermo
Fisher Scientific). The instrument was set to acquire scheduled pairs of
parallel reaction monitoring (PRM) scans in profile mode allowing si-
multaneous detection of both the SNAP-25/SYT-1 peptides and the
corresponding internal standards (IS). Data acquisition and analysis
were performed with Xcalibur software version 2.2 SP1.48 (Thermo
Fisher Scientific) and Pinpoint 1.3.0. Levels of SNAP-25tot (amino acids
Ac2-16) and SNAP-25aa40 (amino acids 32–40) were calculated by
multiplying the ratio of the LC-MS peak areas with the concentration of
the corresponding IS.
2.11. Lactate dehydrogenase (LDH) assay
To estimate the viability of the cells, we performed the LDH release
assay. hiPSC were differentiated to mature cortical neurons. As a 0%
viability control, mature cortical neurons were lysed with 1% Triton X-
100 (Sigma Aldrich) (1% v/v to cell-conditioned media). The unlysed
(samples) and lysed cortical neurons (controls) were incubated at 37 °C
for 30min to release LDH. Thereafter, the unlysed or lysed cells to-
gether with cell-conditioned media were centrifuged at 360×g for
5min and the supernatants were collected. The freshly collected su-
pernantants (250 μL) were sent to Clinical Chemistry Laboratory at
Sahlgrenska University Hospital, Gothenburg, Sweden for analysis. In
brief, the LDH assay was performed using the LDH activity test kit as
per manufacturer's instructions (Roche Diagnostics Scandinavia AB,
03004732122) on the fully automated analyzer Cobas e 501 module
(Roche, Germany). The working range for the assay was
0.167–16.70 μkat/L.
2.12. Statistical analysis
Mean values were compared using two-way analysis of variance
(ANOVA) followed by Tukey-Kramer post hoc analysis. Statistical sig-
nificance was defined as p < 0.05. All statistical analyses were per-
formed using SPSS (IBM SPSS Statistics for Windows, Version 22.0.
Armonk, NY: IBM Corp).
3. Results
3.1. Characterization of cells during differentiation from hiPSC towards
cortical neurons
A schematic representation of hiPSC differentiation to cortical
neurons is shown in Fig. 1A. The cells differentiated gradually from
hiPSC to neuro-progenitors followed by immature and mature cortical
neurons. During differentiation, cell morphology was monitored using
phase contrast microscopy. Fig. 1B shows the morphological changes
occurring during differentiation to cortical neurons. At d0, hiPSC were
cultured at 95–100% confluency. The cells formed neural rosettes be-
tween d15 to d25 of differentiation (neural rosettes at d17 are shown in
Fig. 1B). The contacts between neurites were first observed after d30 of
differentiation and more thereafter (d45 and d60 are shown). The
neurons were further maintained for two to five months which led to a
substantial increase in the neuritic network and formation of thick
bundles of neurites. Extensive neuritic networks are shown for d120
and d165 of differentiation.
To characterize the neurons, immunocytochemistry was performed
during hiPSC differentiation to cortical neurons. Pluripotent markers of
stem cells, octamer-binding transcription factor-4 (OCT-4) and
homeobox protein NANOG (NANOG) (Fig. 2A and B), were expressed
highly on d0 which suggested that these cells are stem cells. NANOG
and OCT-4 expression weakened on d4 of differentiation suggesting
that these cells loose pluripotency. KI-67, a proliferation marker had
similar staining intensities on d0 and d4 of differentiation (showing a
typical KI-67 nuclear staining pattern depending on cell cycle stage
(Sobecki et al., 2016; Verheijen et al., 1989)), which indicated that
these cells have the ability to proliferate during this stage. Nestin, a
marker for neuro-progenitors (Supplementary Fig. 2A) was already
expressed on d15 of differentiation. Further, paired box protein-6 (PAX-
6) (Fig. 2C), another neuro-progenitor marker was highly expressed on
d20 which suggested that the cells are neuro-progenitors at this stage.
PAX-6 expression weakened on d40 as compared to d20, indicating that
neuro-progenitors were decreased during this period. Neuron-specific
class III beta-tubulin (TUJ-1) expression increased markedly from d30
to d60 of differentiation (Fig. 2D) indicating neuritic development
during differentiation. Further, cortical markers for deep layer neurons,
COUP-TF interacting protein-2 (CTIP-2) and T-Box, Brain-1 (TBR-1)
were expressed during this period (d40 is shown in Supplementary
Fig. 2B and C). Synaptic vesicle glycoprotein-2 (SV-2), a pre-synaptic
protein, and post-synaptic density protein-95 (PSD-95) (Fig. 2E and F)
were weakly expressed on d60 of differentiation. On d120, SV-2 and
PSD-95 expression increased markedly and became punctate,
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suggesting that synapses matured during this period. Furthermore,
markers for upper layer cortical neurons; POU class 3 homeobox-2
(BRN-2) and Cut-Like Homeobox-1 (CUX-1) were first expressed during
this stage (d90 and d105 are shown respectively in Supplementary
Fig. 2D and E). These stainings indicate the step-wise expression of stem
cells, neuro-progenitors, immature and mature cortical neurons during
hiPSC differentiation to cortical neurons. In addition, the cells used in
this study have been characterized extensively in a previous publication
from our group (Bergström et al., 2016), which described the mRNA
expression of transcription factors for stem cells, neuro-progenitors and
cortical neurons and immunocytochemistry images for glial fibrillary
acidic protein (GFAP), an astrocyte marker and the vesicular glutamate
transporter 1 (vGLUT1). GFAP expression increased from d60 to d90
while vGLUT1 became punctate on d90 of differentiation (Bergström
et al., 2016). Previously, we have also shown that evoked action po-
tentials could first be measured from d100 and onwards (Bergström
et al., 2016). This indicates that these neurons have functional synapses
around d100 of differentiation.
3.2. Expression and secretion of NRGN during hiPSC differentiation to
cortical neurons
NRGNmRNA expression was first observed on d10 of differentiation
followed by a biphasic increase from d18 to d60 (Fig. 3A). After d75,
Fig. 1. (A) Schematic representation of hiPSC differentiation stages during development to cortical neurons: hiPSC (undifferentiated cells), neuro-progenitors,
immature and mature neurons. (B) Cell morphology and neurite network, as observed during hiPSC differentiation to cortical neurons. Phase contrast images at d0
show hiPSC maintained at high density (95–100% confluency); d17 illustrates the formation of rosette structures (arrows); d45 depicts single cells forming neurites
(arrows) during early cortical development; d60, neurite connections increase and a network is formed. Further maturation of cortical neurons coincides with
establishment of an extensive neuronal network as shown on d120 and d165 of differentiation. Scale bar= 100 μm.
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there was a tendency towards a gradual increase in NRGN mRNA ex-
pression until d135 of differentiation, when the highest expression was
detected. Thereafter, NRGN mRNA expression decreased gradually.
Intracellular NRGN protein was first detected on d10 and there was a
gradual increase of NRGN expression from d18 to d135. NRGN was
expressed at the highest level on d135 as shown in Fig. 3B and
Supplementary Fig. 1A. A reduction of NRGN expression was observed
after d135, although the levels remained clearly detectable. NRGN se-
cretion to the media was first detected on d10 (Fig. 3C). The NRGN
secretion pattern correlated well (Spearman rank correlation coefficient
r= 0.64, p= 0.007) with the NRGN mRNA expression as shown in
Supplementary Fig. 3. The highest secretion of NRGN was detected on
d135 of differentiation. After d135, the secreted levels of NRGN de-
creased.
Fig. 2. Neuronal and synaptic maturation during differentiation of hiPSC to cortical neurons. Representative images from immunocytochemistry staining during
differentiation. (A and B) NANOG and OCT-4 were strongly stained on d0 and the stainings became weak on d4, while KI-67 had similar staining intensities on d0
and d4. (C) PAX-6, a primary neuro-progenitor expression decreased from d20 to d40 of differentiation. (D) Staining for neuron specific tubulin, TUJ-1 was weak on
d30 but strong staining was observed on d60. (E) SV-2, a pre-synaptic protein, staining was weak on d60. On d120, a strong punctuate staining was observed
(arrows). (F) PSD-95, a post-synaptic density protein, staining was weak on d60. On d120, the staining had intensified and became punctate (arrows). Green or
red= protein of interest, blue=nuclei (DAPI), Scale bar= 20 μm.
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3.3. Expression and secretion of GAP-43 during hiPSC differentiation to
cortical neurons
GAP-43 mRNA was first expressed on d18 of differentiation
(Fig. 4A). A marked increase in GAP-43 mRNA was observed until d60
of differentiation, when GAP-43 mRNA was expressed at the highest
level. Thereafter, the GAP-43 expression decreased. Intracellular GAP-
43 protein levels (Fig. 4B and Supplementary Fig. 1B) followed the
pattern of GAP-43 mRNA expression (Spearman rank correlation coef-
ficient r= 0.756, p= 0.001). GAP-43 protein levels were stable, with
slightly decreased levels of GAP-43 after d165 of differentiation. Se-
cretion of total GAP-43 to media was first noted on d18 of differ-
entiation (Fig. 4C). GAP-43 was secreted at low concentration from d18
to d45. Thereafter, there was a marked increase of secreted GAP-43
until d135. After d135, GAP-43 secretion decreased.
3.4. Expression and secretion of SYT-1 during hiPSC differentiation to
cortical neurons
SYT-1 mRNA was expressed throughout the differentiation in-
cluding d0 (Fig. 5A). There was a gradual increase in the expression of
SYT-1 mRNA from d0 to about d165. SYT-1 mRNA was expressed the
most during d135 to d165 and on d210. Intracellular expression of SYT-
1 protein was first noted on d25 (Fig. 5B and Supplementary Fig. 1C).
The SYT-1 protein pattern did not follow SYT-1 mRNA expression
during d0 to d18, when SYT-1 protein was undetectable. Thereafter,
there was a gradual increase in SYT-1 protein until d105, when protein
levels were the highest. After d150, a tendency towards decreased SYT-
1 protein was observed. Secreted SYT-1 was monitored by IP followed
by PRM mass spectrometry (Fig. 5C). SYT-1 was secreted at relatively
high concentrations on d0 compared to d10 through d45. There was a
gradual increase in secretion during d60 to d90 with the highest levels
seen on d180 of differentiation.
3.5. Expression and secretion of SNAP-25 during hiPSC differentiation to
cortical neurons
SNAP-25 mRNA was first expressed on d18; thereafter, there was a
gradual increase in the expression of SNAP-25 mRNA until d165
(Fig. 6A). Intracellular SNAP-25 protein was first noted on d18 of dif-
ferentiation. Thereafter, a marked increase in SNAP-25 protein was
seen until d75 and after d135 a slight reduction was observed (Fig. 6B
and Supplementary Fig. 1D). Secreted SNAP-25 was monitored by IP
followed by PRM mass spectrometry. Our method measures the levels
of total SNAP-25 (SNAP-25tot) shown in Fig. 6C and SNAP-25 amino
acid 40 peptide (SNAP-25aa40) shown in Fig. 6D. SNAP-25tot measures
all soluble forms of SNAP-25, whereas SNAP-25aa40 only measures the
longer soluble forms (including at least amino acid 40). SNAP-25 was
first secreted on d25 at very low concentrations. There was a gradual
increase in secreted SNAP-25 during d60 to d135; thereafter, the se-
creted concentrations plateaued between d135 to d165 followed by a
tendency towards decreased secretion of SNAP-25. The highest SNAP-
25tot secretion was detected on d135 (Fig. 6C) while the highest SNAP-
25aa40 concentrations were detected on d120 of differentiation
(Fig. 6D).
3.6. Localization of synaptic proteins in mature cortical neurons
Synaptic proteins were highly expressed in mature cortical neurons
as detected by western blot. Therefore, immunocytochemistry was
performed on mature cortical neurons on d120 of differentiation.
Synaptic proteins of interest were localized by co-staining with either
pre- or post-synaptic protein as shown in Fig. 7. NRGN was co-stained
with PSD-95, a dendritic marker; the arrow points at the localization of
NRGN and PSD-95 in dendrites (Fig. 7A). A punctate staining for PSD-
95 was observed. GAP-43 was co-stained with tau, an axonal protein;
the arrows point at the localization of GAP-43 and tau in axons
Fig. 3. hiPSC-derived cortical neurons express and
secrete NRGN during differentiation. (A) Expression
of NRGN mRNA as detected by quantitative PCR;
NRGN mRNA was first expressed on d10 at low level.
During d18 to d60, there was differential NRGN
mRNA expression. When cortical neurons matured,
NRGN mRNA levels increased gradually from d90 to
d135, when it was expressed the highest. There was a
trend towards decreased expression of NRGN mRNA
after d165. NRGN mRNA was normalized to the
average of HPRT-1, RPL-27 and RPL-30 genes. NRGN
mRNA normalized change at each differentiation
time point was related to the highest NRGN mRNA
expression, which was set to 1. For a summary of
assigned significances for the measured changes of
NRGN mRNA, see Supplementary Table 1. (B) In-
tracellular NRGN protein levels were detected by
western blot. NRGN was first detected on d10 and its
levels increased between d18 and d135. On d135,
NRGN levels were the highest; thereafter there was a
trend towards decreased NRGN levels. NRGN protein
levels were normalized to GAPDH and its fold change
in each differentiation was related to the highest
NRGN protein level, which was set to 1. Re-
presentative bands of NRGN and GAPDH are shown.
The summary of assigned significances for the mea-
sured changes of NRGN protein level is shown in
Supplementary Table 2. (C) Total NRGN secretion
was detected by ELISA and NRGN was first secreted
on d10. NRGN secretion increased gradually from
d90 to d135, when NRGN was secreted the most;
thereafter a trend towards decreased secretion was observed. The summary of assigned significances for the changes of secreted NRGN concentrations are sum-
marized in Supplementary Table 3. Bars represent mean± SEM. For intracellular expression of NRGN mRNA and protein, n=4 (except from d165 to d210 where
n= 2) and for secreted NRGN, n= 5 (except from d165 to d210 where n= 3).
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(Fig. 7B). Pre-synaptic proteins, SYT-1 and SNAP-25 were co-stained;
they were co-expressed in the same compartment as indicated by ar-
rows (Fig. 7C). A punctate staining for SV-2 and SNAP-25 was observed
in the same compartment as indicated by arrows (Fig. 7D).
3.7. Release of LDH and GAPDH to cell-conditioned media
To confirm that the synaptic proteins found in cell-conditioned
media during neuronal differentiation were secreted, rather than re-
leased through damaged cell membranes due to cell death, LDH activity
was measured on d135 differentiated cells (Supplementary Fig. 4A),
which was the time point when the highest concentrations of synaptic
proteins were detected in cell-conditioned media. Cell-conditioned
media contained very low LDH activity, 0.285 μkat/L (2.4%; as com-
pared to LDH activity of 11.9 μkat/L in triton-X100 treated cells set to
100% (control)). The limit of detection for the assay was 0.17 μkat/L.
Further to support these findings, we performed western blots to detect
GAPDH in cell-conditioned media on d0, d18, d60 and d120 of differ-
entiation (Supplementary Fig. 4B). We detected very weak bands on d0,
d60 and d120 of differentiation and there were no correlations between
secreted synaptic protein levels (NRGN, GAP-43, SYT-1 and SNAP-25)
and GAPDH densitometry (arbitrary units) (Correlations for NRGN and
GAP-43 are shown in Supplementary Fig. 4C and 4D).
4. Discussion
hiPSC, when undergoing an in vitro differentiation process to induce
the same developmental steps as observed during human fetal brain
development, provide an opportunity to study molecular changes
during human cortical development (Shi et al., 2012). Here, we used
this model to study temporal changes in the expression and secretion of
a number of synaptic proteins during the differentiation to cortical
neurons. We found that NRGN, GAP-43 and SNAP-25 were first ex-
pressed and secreted between d10 to d25, when neurite outgrowth was
not yet observed. SYT-1 mRNA was expressed and secreted already on
d0 of differentiation. NRGN, SNAP-25 and SYT-1 were expressed at the
highest levels after d90, when mature synapses were formed while
GAP-43 was expressed the highest level already on d60 of differentia-
tion, when neurite outgrowth was intense. For all these synaptic pro-
teins, the highest secretion was observed between d120 and d135,
when functional synapses had formed. The expression of synaptic
proteins thus followed the timing of development of cortical neurons
and network formation.
The hiPSC-derived cortical neurons used in this study are char-
acterized here and also elsewhere (Bergström et al., 2016). On the basis
of cell morphology, immunocytochemistry, gene expression and elec-
trophysiological data shown in this study and by Bergström et al.
(2016), hiPSC differentiation to cortical neurons can be divided into (i)
stem cell stage (d0), (ii) neuro-progenitor stage (d11 to d25), (iii) im-
mature cortical neurons (d30-d75) and (iv) mature cortical neurons
(d90 and beyond). During stem cell stage, hiPSC were maintained at
100% confluency and the cells expressed the pluripotency markers,
NANOG and OCT-4. At the neuro-progenitor stage, the neural rosette
structures appeared and pluripotency genes disappeared, and the
markers for neuro-progenitors, nestin and PAX-6 were first expressed.
The immature cortical neuronal stage was characterized by neurite
outgrowth and formation of first neurite connections followed by
neurite network formation. During this stage, markers for deep layer
cortical neurons, CTIP-2 and TBR-1 were first expressed. Further,
during this stage there was a marked increase in TUJ-1 expression,
while synaptic markers, SV-2 and PSD-95 were expressed weakly and
the neurons fired low to moderate evoked action potentials. Mature
cortical neurons were formed around d90 and beyond. During this
period, markers for upper layer cortical neurons, BRN-2 and CUX-1
Fig. 4. GAP-43 mRNA and protein expression during
hiPSC differentiation to cortical neurons. (A)
Expression of GAP-43 mRNA was detected by quan-
titative PCR; GAP-43 mRNA was first expressed on
d18 of differentiation. A marked increase in GAP-43
mRNA expression was seen between d18 and d60.
On d60, GAP-43 mRNA was expressed the highest;
thereafter the levels decreased and plateaued until
d165 of differentiation. After d165, there was a trend
towards decreased expression of GAP-43. GAP-43
mRNA was normalized to the average of HPRT-1,
RPL-27 and RPL-30 mRNA. GAP-43 mRNA normal-
ized change at each differentiation time point was
related to the highest GAP-43 mRNA expression,
which was set to 1. For a summary of assigned sig-
nificances for the measured changes of GAP-43
mRNA, see Supplementary Table 4. (B) GAP-43
protein levels were detected by western blot and
GAP-43 protein was first detected on d18. GAP-43
levels increased gradually between d18 and d60,
when it was expressed the highest. Thereafter, GAP-
43 levels slightly decreased and plateaued until
d165, which was followed by a gradual decrease in
GAP-43 levels. GAP-43 levels were correlated to
GAPDH and GAP-43 fold change in each differ-
entiation was related to the highest GAP-43 protein
level, set to 1. Representative bands of GAP-43 and
GAPDH are shown. The summary of assigned sig-
nificances for the measured changes of GAP-43 pro-
tein is shown in Supplementary Table 5. (C) Total
GAP-43 secretion was detected by ELISA; GAP-43
was first observed to be secreted on d18. Between
d18 and d45, secreted GAP-43 levels plateaued; thereafter there was a trend towards gradual increase of secreted GAP-43 between d60 and d120. On d120, GAP-43
was secreted the highest followed by a gradual decrease in GAP-43 secretion. The summary of assigned significances for the changes of secreted GAP-43 con-
centrations is summarized in Supplementary Table 6. Bars represents mean± SEM. For intracellular expression of GAP-43 mRNA and protein, n=4 (except from
d165 to d210 where n= 2) and for secreted GAP-43, n= 5 (except from d165 to d210 where n=3).
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were first expressed. The neuritic network was further increased and
thick bundles of neurites were formed. In addition, the synaptic mar-
kers showed punctate localizations. The neuritic network activity was
enhanced and the neurons spontaneously fired action potentials sug-
gesting the maturation of functional synapses. The hiPSC differentiation
to cortical neurons followed step-wise maturation whereby stem cells
appear first followed by their gradual transition to neuro-progenitors.
Thereafter, deep-layer neurons were first expressed in immature cor-
tical neurons followed by expression of upper-layer neurons in mature
cortical neurons. The stages are summarized in Fig. 1A.
Taken together, increased mRNA expression, intracellular protein
levels and secretion of synaptic proteins coincided with the develop-
ment of neurites and synapses. During neuro-progenitor stage, when
neurite outgrowth was absent, NRGN, GAP-43, SNAP-25 and SYT-1
were expressed at low levels. However, expression of the synaptic
proteins increased gradually as the neuritic network started to form at
the stage of immature neurons. Increased expression of GAP-43 in im-
mature neurons coincided with the formation of neurite connections.
Further increases in the expression of NRGN, SNAP-25 and SYT-1 fol-
lowed the formation of neuritic networks and thick bundles of neurites.
Our expression results support an association of NRGN, GAP-43, SNAP-
25 and SYT-1 in synaptic sprouting, axonal outgrowth, axonal
branching, synaptic plasticity, and synaptogenesis, as suggested else-
where (Alvarez-Bolado et al., 1996; Baker et al., 2015; Benowitz and
Routtenberg, 1997; Diez-Guerra, 2010; Greif et al., 2013; Zhong et al.,
2015). Furthermore, a previous study showed that increased expression
of synaptic proteins was associated with synapse stabilization (Pinto
et al., 2013).
NRGN mRNA was expressed in two phases during early differ-
entiation (neuro-progenitors and immature neurons), thereafter NRGN
protein expression increased gradually and peaked in mature neurons.
A study on rat telencephalon suggests a bi-phasic NRGN mRNA
expression; an early phase and a juvenile phase. In addition, NRGN
protein in rats is first expressed on embryonic day 18 and its expression
increased markedly at birth (postnatal stage-P1) (Alvarez-Bolado et al.,
1996). A study on monkeys also suggests NRGN mRNA expression to be
developmentally regulated (Higo et al., 2006). These studies highlight
the differential expression of the NRGN gene during early development
(corresponding to neuro-progenitors and immature neurons in our
model) and suggest NRGN to be expressed the highest in mature neu-
rons.
GAP-43 mRNA expression and intracellular protein levels showed
the same profile during neuronal differentiation. The secretion of GAP-
43 was delayed in comparison to its intracellular protein levels (by
about 4 weeks). The increased levels of GAP-43 protein in immature
neurons coincided with neuritic branching, which is in agreement with
a possible role of GAP-43 in this process. Our expression results support
the increase in GAP-43 protein levels during embryonic brain devel-
opment in rodent models (Capone et al., 1991; Mahalik et al., 1992).
SYT-1 protein levels were first detected in neuro-progenitors when
neither neurite outgrowth nor synaptogenesis were observed. Our
finding is in line with a previous report that suggests that SYT-1 is
expressed well before the beginning of synaptogenesis both in vivo and
in vitro (Greif et al., 2013).
SNAP-25 mRNA expression and protein levels increased gradually
during the formation of immature cortical neurons and were highest in
mature neurons. One study in developing rat cerebral cortex suggests
that SNAP-25 protein is highly expressed on post-natal day 10 (P10)
and (P60), after which SNAP-25 levels decrease (Sidor-Kaczmarek
et al., 2004). Increased expression of SNAP-25 in mature neurons may
reflect the establishment of neuritic networks.
Our novel, sensitive methods to detect NRGN, GAP-43, SYT-1 and
SNAP-25 in bio-fluids make the detection of these synaptic proteins in
cell-conditioned media possible. The analysis of NRGN, GAP-43, SYT-1,
Fig. 5. SYT-1 mRNA and protein expression during
hiPSC differentiation to cortical neurons. (A) SYT-1
mRNA was detected by quantitative PCR and was
first expressed on d0. There was a trend towards
increased expression of SYT-1 mRNA between d0 and
d165. SYT-1 mRNA levels were normalized to the
average of HPRT-1, RPL-27 and RPL-30 genes and
SYT-1 mRNA fold change in each differentiation was
related to the highest SYT-1 mRNA expression, set to
1. For a summary of assigned significances for the
measured changes of SYT-1 mRNA, see
Supplementary Table 7. (B) SYT-1 protein levels
were detected by western blot and were not observed
until d18 of differentiation. Thereafter, there was a
gradual increase in SYT-1 levels until d105, when
expression was the highest. After d150, SYT-1 levels
decreased. SYT-1 protein levels were correlated to
GAPDH and SYT-1 fold change in each differentia-
tion was related to the highest SYT-1 protein level,
set to 1. Representative bands of SYT-1 and GAPDH
are shown. The summary of assigned significances
for the measured changes of SYT-1 protein is shown
in Supplementary Table 8. (C) Secreted SYT-1 was
detected by immuno-precipitation (IP) followed by
parallel reaction monitoring (PRM) mass spectro-
metry; the assay targets mainly the SYT-1 C2A cal-
cium binding domain. Fig. 4C show that SYT-1 was
secreted at high concentrations on d0. The secreted
SYT-1 decreased remarkably from d0 until d45.
Thereafter, SYT-1 secretion increased gradually from
d60 to d90. After d180, there was a trend towards
decreased secretion of SYT-1. The summary of as-
signed significances for the changes of secreted SYT-
1 concentration is summarized in Supplementary Table 9. Bars represent mean±SEM. For intracellular expression of SYT-1 mRNA and protein, n=4 (except from
d165 to d210 where n= 2) and secreted SYT-1, n=5 (except from d165 to d210 where n= 3).
F.H. Nazir et al. Neurochemistry International 121 (2018) 38–49
46
and SNAP-25 secretion to CSF has previously been focused in context of
neurodegeneration including AD (Brinkmalm et al., 2014; Sjogren
et al., 2001; Thorsell et al., 2010; Öhrfelt et al., 2016). However, the
secretion of synaptic proteins from human cellular models during de-
velopment has not been investigated previously.
The secretory pattern of NRGN followed the NRGN mRNA fold
change. NRGN was first secreted by neuro-progenitors. During neuro-
progenitor and immature cortical neuronal stages, NRGN secretion was
low. As neurons matured and functional synapses had formed, NRGN
secretion increased in mature cortical neurons. The secretory pattern of
GAP-43 protein suggests that GAP-43 may be required during early
development of immature neurons. When cortical neurons mature,
GAP-43 may be needed for synaptic stabilization, as suggested by an
earlier study (Allegra Mascaro et al., 2013). The SYT-1 expression
pattern was puzzling. SYT-1 mRNA was detected already at the hiPSC
stage and so was SYT-1 protein secretion. However, intracellular SYT-1
Fig. 6. SNAP-25 mRNA and protein expression
during hiPSC differentiation to cortical neurons. (A)
SNAP-25 mRNA was detected by quantitative PCR
and its expression was first observed on d18. SNAP-
25 mRNA expression increased gradually during
differentiation until d165, when SNAP-25 mRNA was
expressed the highest. SNAP-25 mRNA was normal-
ized to the average of HPRT-1, RPL-27 and RPL-30
mRNA levels. SNAP-25 mRNA fold change in each
differentiation was related to the highest SNAP-25
mRNA expression, set to 1. For a summary of as-
signed significances for the measured changes of
SNAP-25 mRNA, see Supplementary Table 10. (B)
SNAP-25 protein was first detected on d18 by wes-
tern blot. SNAP-25 protein levels increased gradually
from d18 to d75. After d105, SNAP-25 levels pla-
teaued until d135, followed by reduction in the le-
vels of SNAP-25. SNAP-25 levels were correlated to
GAPDH and SNAP-25 fold change in each differ-
entiation was related to the highest SNAP-25 ex-
pression, set to 1. Representative bands of SNAP-25
and GAPDH are shown. The summary of assigned
significances for the measured changes of SNAP-25
protein is shown in Supplementary Table 11. (C and
D) IP followed by PRM mass spectrometry was used
to detect secreted SNAP-25; SNAP-25tot (shown in
C), and SNAP-25aa40 (shown in D). (C) SNAP-25tot
represents all soluble forms of SNAP-25 and was first
secreted on d25. The secretion of SNAP-25tot in-
creased markedly from d60 to d135, when it was
secreted the highest. Thereafter, the secreted con-
centrations of SNAP-25tot plateaued until d165 fol-
lowed by decreased secretion. (D) SNAP-25aa40 measures the longer soluble forms (including at least amino acid 32–40). There was a gradual increase of secreted
SNAP-25aa40 between d60 and d105, followed by a marked increase from d105 to d120, when it was secreted the most. After d165, a trend towards decreased
secretion of SNAP-25aa40 was observed. The summary of assigned significances for the changes of secreted SNAP-25tot and SNAP-25aa40 concentrations are
summarized in Supplementary Table 12 and 13, respectively. Bars represents mean± SEM. For intracellular expression of SNAP-25 mRNA and protein, n=4 (except
from d165 to d210 where n= 2) and for secreted SNAP-25, n=5 (except from d165 to d210 where n= 3).
Fig. 7. Localization of synaptic proteins in mature corical neurons. Representative images at d120 from immunocytochemistry staining of mature cortical neurons.
(A) NRGN (green) and PSD-95 (red), post-synaptic proteins are co-expressed in the same compartment (arrows). (B) GAP-43 (green) and tau (red) are stained
together in axons (arrows). (C) SYT-1 (green) and SNAP-25 (red), pre-synaptic proteins are co-stained in the same compartment (arrows). (D) SNAP-25 (green) and
SV-2 (red), pre-synaptic proteins are co-expressed in the same compartment (arrows). blue=nuclei (DAPI), Scale bar= 10 μm.
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expression was not detectable until more mature differentiation stages.
This result suggests that SYT-1 may play distinct roles at early and late
differentiation stages. The secretory profile of SNAP-25 showed that
SNAP-25 was not detected in stem cells or neuro-progenitors; it was
first released when markers for immature neurons were expressed and
it peaked when mature synapses were formed. Taken, together, the
secretion of synaptic proteins was highest in mature cortical neurons,
which coincides with the formation of stable synaptic networks. As we
only used one protocol for differentiation of cortical neurons, the results
should be confirmed using other protocols.
As no correlations were found between secreted synaptic proteins
and GAPDH in cell-conditioned media from stem cells, neuro-progeni-
tors, immature or mature cortical neurons, and LDH activity was low in
cell-conditioned media from mature neurons, the secretion of these
synaptic proteins was most likely an active process. One possible reason
for their secretion could be physiological protein turnover, causing
synaptic proteins to be released from synapses once they have executed
their actions. It has been reported that general synaptic protein half-life
is 99 h (Alvarez-Castelao and Schuman, 2015). The secretion may also
reflect synaptic remodeling of the cortical connectome during devel-
opment. Synaptic proteins may also be secreted as an inherent part of
synaptic transmission.
5. Conclusion and significance
This study describes a detailed expression and secretory profile of
synaptic proteins in a model reflecting human fetal cortical develop-
ment. This implicates that increased expression of synaptic proteins
reflects an increase in neurite outgrowth followed by formation of sy-
naptic networks. Further, it implicates that mature neurons are more
prone to secrete synaptic proteins than neuro-progenitors and immature
neurons. This study should facilitate the possibilities to determine the
particular role and function of synaptic proteins during cortical devel-
opment and help dissect the mechanism for synaptic protein release to
CSF, as seen in neurodegenerative disease, AD in particular.
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